Sales of “Olainfarm” grew by 35% in JanuaryPreliminary data on consolidated sales of AS “Olainfarm” during January of 2012, shows that sales have increased by 35% compared to the similar period one year ago and have reached 3.52 million lats (5 million euros). Biggest sales increases were achieved in Latvia (by 389%), Taiwan (by 259%), Ukraine (by 88%), and Russia (by 49%). Major sales markets of AS “Olainfarm” during January were Russia, Ukraine, Latvia, Belarus and the USA.Olaine, February 15, 2012, 2012-02-15 15:01 CET --
Consolidated sales, January 2012
|
|
Share in total sales |
Increase to January 2011 |
|
Russia |
38% |
49% |
|
Ukraine |
28% |
88% |
|
Latvia |
19% |
389% |
|
Belarus |
5% |
-51% |
|
USA |
3% |
NA |
|
Taiwan |
1% |
259% |
|
Bulgaria |
1% |
-54% |
|
Spain |
1% |
NA |
|
Azerbaijan |
1% |
7% |
|
Kyrgyzstan |
1% |
NA |
|
Other |
2% |
-87% |
|
Total |
100% |
35% |
Sales made by pharmacies owned by AS “Olainfarm” in January 2012 were 0.52 million lats (0.74 million euro).
Thus, according to preliminary unconsolidated sales figures of AS “Olainfarm” for January of 2012, unconsolidated sales made during January were 3.02 million lats (4.29 million euro), which represents an increase by 16% compared to unconsolidated sales made in January 2011. Biggest sales increases were achieved in Taiwan (by 259%), Ukraine (by 88%), Russia (by 49%), Latvia (by 25%). According to unconsolidated sales, the major sales markets of AS “Olainfarm” in January 2012 were Russia, Ukraine, Belarus, Latvia and the USA.
Unconsolidated sales, January 2012
|
|
Share in total sales |
Increase to January 2011 |
|
Russia |
44% |
49% |
|
Ukraine |
33% |
88% |
|
Belarus |
6% |
-51% |
|
Latvia |
6% |
25% |
|
USA |
4% |
NA |
|
Taiwan |
2% |
259% |
|
Bulgaria |
1% |
-54% |
|
Spain |
1% |
NA |
|
Azerbaijan |
1% |
7% |
|
Kyrgyzstan |
1% |
NA |
|
Other |
2% |
-87% |
|
Total |
100% |
16% |
Although no forecasts of AS “Olainfarm” are formally approved, for planning purposes the Board of the Company is using forecasts according to which the unconsolidated sales of the company in 2012 will reach 40.6 million lats (57.8 million euro), which represents an increase by 12% compared to sales made during 2011. According to these preliminary unconsolidated sales figures, during January 2012, 7.4% of sales forecasts for the year 2012 are already met.
AS Olainfarm is one of the biggest pharmaceutical companies in Latvia with nearly 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
AS Olainfarm
Cell: +371 26448873
e-mail: Salvis.Lapins@olainfarm.lv
|